Tout DSpace

Afficher la notice abrégée

Insulin resistance intervention after stroke trial of pioglitazone: Is this perhaps the end of the beginning?

dc.creatorNtaios G., Kent T.A.en
dc.date.accessioned2023-01-31T09:40:32Z
dc.date.available2023-01-31T09:40:32Z
dc.date.issued2016
dc.identifier10.1161/STROKEAHA.116.013230
dc.identifier.issn00392499
dc.identifier.urihttp://hdl.handle.net/11615/77274
dc.description.abstract[No abstract available]en
dc.language.isoenen
dc.sourceStrokeen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84969916149&doi=10.1161%2fSTROKEAHA.116.013230&partnerID=40&md5=6355a9fa65b978524e25ae4610832509
dc.subjectpioglitazoneen
dc.subject2,4 thiazolidinedione derivativeen
dc.subjectantidiabetic agenten
dc.subjectperoxisome proliferator activated receptor gammaen
dc.subjectpioglitazoneen
dc.subjectcerebrovascular accidenten
dc.subjectclinical practiceen
dc.subjectdaily life activityen
dc.subjectdiabetes mellitusen
dc.subjectdiet restrictionen
dc.subjectethnic differenceen
dc.subjecthumanen
dc.subjecthyperglycemiaen
dc.subjectinsulin resistanceen
dc.subjectphysical activityen
dc.subjectpriority journalen
dc.subjectsedentary lifestyleen
dc.subjectShort Surveyen
dc.subjectagonistsen
dc.subjectcerebrovascular accidenten
dc.subjectcomplicationen
dc.subjectimpaired glucose toleranceen
dc.subjectHumansen
dc.subjectHypoglycemic Agentsen
dc.subjectInsulin Resistanceen
dc.subjectPPAR gammaen
dc.subjectPrediabetic Stateen
dc.subjectStrokeen
dc.subjectThiazolidinedionesen
dc.subjectLippincott Williams and Wilkinsen
dc.titleInsulin resistance intervention after stroke trial of pioglitazone: Is this perhaps the end of the beginning?en
dc.typeotheren


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée